glp 1 drugs and fatty liver GLP-1 Receptor Agonists in Non-Alcoholic Disease: Current Evidence Future Perspectives GLP-1 mimetics as a potential

caloric restriction during growth periods can affect final adult height, and whether orforglipron's appetite-suppressing effects would impair normal growth trajectories requires dedicated study

Cell Signal

Overall, we favor the use of longer-acting over shorter-acting GLP-1 receptor agonists, but the choice should take into account individual clinical factors, patient preferences, risks, and benefits

10.1097/MCO.0b013e328302f414 82 Mauvais-JarvisF.CleggD

Cosmetic weight loss and "longevity": These medications are being marketed to people who do not meet medical criteria, including those who simply feel pressured to be thinner

PLoS One 2015;10:e0126769